General Comments / Chat, page-600

Race Oncology has world class, incredible calibre people in the management and team .
As well as some of the best , top haematology oncologists & renowned medical researchers.

All of these people have many other things they could choose to do with their time and in their work - but choose to be here , wanted to work for Race , to bring bisantrene into full registration as a very good oncology drug.
*This has been very compelling as the aim for all in management and the team who have chosen to join Race Oncology.

They are working for lower salaries & remuneration.
All were and still are confident to accept out of the money options primarily as remuneration for their hard work.

* Recheck the credentials of Prof Borje Andersson , at MD Anderson (Cancer ) Centre - the preeminent Cancer research and treatment facility , 9 of the last 10 years in the whole of America .
He is the inventor of the global standard of care co- treatment given when receiving a bone marrow transplant . He researched and developed it. He has as his life work goal to further increase survival and cure rates in leukaemia patients, *particularly for AML * .
Residual cancer cells , or refractory ( difficult- unresponsive to existing standard oncology treatments or not responsive enough ) cancer , is the reason people die of course from their cancers other than an adverse reaction or illness -if they otherwise can tolerate and respond to treatment & receive a matching marrow transplant .

* Recheck Dr John Cullity’s past achievements and his lead roles in employment . He himself also a top haematology oncologist ( past employment including management of drug acquisitions for Sanofi )

These leading oncologists and specialists as well as our highly qualified and competent Dr Tillet as CFO and dual CEO , & new ex- Johnson and Johnson Asia Pacific CEO as well.

Apart from the huge amount of data held , from over 40 clinical trials , enormous work done - *Bisantrene is a Phase 3 asset** , and had past European registration .
All information , colossal amounts shows proof of efficacy - and people alive today after over 30 years also —says :
•bisantrene works ,
•is very needed ! for dire cancers including AML and breast cancer, and
•exhibits lower , notably less toxicity than the anthracyclines especially doxorubicin.
•safety and dose protocol regimes also fairly well understood .

Ultra advanced situation already with Bisantrene , and Race - 5 years already . Says no one is just going to drop this and walk away . Even for the patents and ownership value of bisantrene RAC is undervalued .

I don’t think this is about ‘odds’ , or averages as you say of which stocks might or might not be successful , or about ‘maybe’ .

The company exists - to succeed .